Related content

Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT

By Ou Xueling   Cai Shaohui   Liu Peng   Zeng Jun   He Yuwen   Wu Xinyao   Du Jun  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 5, 2008-05 ,pp. : 525-533

Springer Publishing Company

Access to resources Recommend Favorite

Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells

By Yasumatsu Ryuji   Nakashima Torahiko   Masuda Muneyuki   Ito Aya   Kuratomi Yuichiro   Nakagawa Takashi   Komune Shizuo  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 10, 2004-10 ,pp. : 567-573

Springer Publishing Company

Access to resources Recommend Favorite

Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck

By Kandiloros D.   Eleftheriadou A.   Chalastras T.   Kyriou L.   Yiotakis I.   Ferekidis E.  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 463-470

Humana Press, Inc

Access to resources Recommend Favorite

Identification of circulating tumor cells: a prognostic marker in squamous cell carcinoma of the head and neck?

By Jatana Kris R   Lang Jas C   Chalmers Jeffrey J  

Future Oncology, Vol. 7, Iss. 4, 2011-04 ,pp. : 481-484

Future Medicine

Access to resources Recommend Favorite

Pretreatment tumor standardized uptake value as a prognostic factor in primary head and neck squamous cell carcinoma

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 392-396

Science Publishers

Access to resources Recommend Favorite